entertainment -WSS

entertainment

author：explore 2025-09-29 09:29:55 - browse：464

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

WSS

'A game

Free Covid tests will again be offered to all U.S. households

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

White House drug shortage group privately met with industry

Covid’s new normal has set in amid another rise in cases

'A game

focus

entertainment

focus

Activists slam private health insurers over coverage restrictions

People with substance use disorder deserve online privacy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

My superpower is killing ticks

Duchenne breakthrough therapy leaves behind pioneering families

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The unintended consequences of overturning Roe v. Wade

Apple is now the first public company to be valued at $3 trillion

A cyberattack has disrupted hospitals and health care in several states

hotspot

Why the quest to eradicate polio has stumbled

OTC birth control: A brief history of over the counter pill design

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

What the cancer research community can learn from the Covid response

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Dramatically reducing cancer deaths requires the PASTEUR Act

focus

hotspot

focus

hotspot